iSpecimen Inc. (ISPC)

NASDAQ: ISPC · Real-Time Price · USD
3.000
+0.040 (1.35%)
At close: Dec 20, 2024, 4:00 PM
2.970
-0.030 (-1.00%)
After-hours: Dec 20, 2024, 7:56 PM EST
1.35%
Market Cap 2.89M
Revenue (ttm) 10.39M
Net Income (ttm) -9.52M
Shares Out 962.64K
EPS (ttm) -17.63
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,418,868
Open 3.620
Previous Close 2.960
Day's Range 2.980 - 3.970
52-Week Range 2.760 - 12.200
Beta 1.58
Analysts n/a
Price Target n/a
Earnings Date Nov 7, 2024

About ISPC

iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, clinics, private practice groups, laboratories, blood centers, biobanks, clinical research sites, and cadaveric donation centers. The company develops and operates iSpecimen Marketplace, a proprietary online marketp... [Read more]

Sector Healthcare
IPO Date Jun 17, 2021
Employees 53
Stock Exchange NASDAQ
Ticker Symbol ISPC
Full Company Profile

Financial Performance

In 2023, iSpecimen's revenue was $9.93 million, a decrease of -4.56% compared to the previous year's $10.40 million. Losses were -$11.10 million, 8.33% more than in 2022.

Financial Statements

News

iSpecimen Will Serve as a Preferred Provider of Cancer Biospecimens

Woburn, Massachusetts--(Newsfile Corp. - December 20, 2024) - iSpecimen Inc. (NASDAQ: ISPC), a leading online marketplace for human biospecimens, today announced its strategic initiatives for 2025, ex...

1 day ago - Newsfile Corp

iSpecimen Reports Positive Results on Next Day Quote Program for Researchers and Providers

Woburn, Massachusetts--(Newsfile Corp. - December 13, 2024) - iSpecimen Inc. (NASDAQ: ISPC) ("iSpecimen" or the "Company"), an online global marketplace that connects scientists requiring biospecimens...

8 days ago - Newsfile Corp

iSpecimen Appoints Robert Lim as CEO and Director

Woburn, Massachusetts--(Newsfile Corp. - December 12, 2024) - iSpecimen Inc. (NASDAQ: ISPC) ("iSpecimen" or the "Company"), an online global marketplace that connects scientists requiring biospecimens...

8 days ago - Newsfile Corp

iSpecimen Named Top Competitor in $4.4 Billion USD Market

Biospecimen Market To Exceed $13.5 Billion USD By 2032 Woburn, Massachusetts--(Newsfile Corp. - November 8, 2024) - iSpecimen Inc. (NASDAQ: ISPC) ("iSpecimen" or the "Company"), an online global marke...

6 weeks ago - Newsfile Corp

iSpecimen Releases Cancer Biospecimen Offering; Orders Anticipated of Over $9,500,000 Annually

WOBURN, Mass., Nov. 07, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical ...

6 weeks ago - GlobeNewsWire

iSpecimen Inc. Announces Closing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants

WOBURN, Mass., Oct. 31, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical ...

7 weeks ago - GlobeNewsWire

iSpecimen Inc. Announces Pricing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants

WOBURN, Mass., Oct. 30, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical ...

7 weeks ago - GlobeNewsWire

iSpecimen Secures $1 Million Loan; Appoints Three New Board Members

WOBURN, Mass., Sept. 26, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc.  (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medica...

3 months ago - GlobeNewsWire

iSpecimen Announces 1-for-20 Reverse Stock Split

WOBURN, Mass., Sept. 11, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc.  (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medica...

3 months ago - GlobeNewsWire

iSpecimen Inc. (ISPC) Q2 2024 Earnings Call Transcript

iSpecimen Inc. (NASDAQ:ISPC) Q2 2024 Earnings Conference Call August 6, 2024 8:30 AM ET Company Participants Phil Carlson - IR, KCSA Strategic Communications Tracy Curley - CEO and CFO Leslie Hoyt - ...

4 months ago - Seeking Alpha

iSpecimen Reports Second Quarter 2024 Results

Revenue increased 76% year-over-year to approximately $2.86 million Brielan Smiechowski Named SVP of Sales and Business Development LEXINGTON, Mass., Aug. 06, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc.  ...

4 months ago - GlobeNewsWire

iSpecimen Inc. (ISPC) Q1 2024 Earnings Call Transcript

iSpecimen Inc. (NASDAQ:ISPC) Q1 2024 Earnings Conference Call May 7, 2024 8:30 AM ET Company Participants Phil Carlson - Investor Relations, KCSA Strategic Communications Tracy Curley - Chief Executi...

7 months ago - Seeking Alpha

iSpecimen Reports First Quarter 2024 Results

LEXINGTON, Mass., May 07, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc.  (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medic...

8 months ago - GlobeNewsWire

iSpecimen to Report First Quarter 2024 Financial Results on May 7, 2024

LEXINGTON, Mass., April 25, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc.  (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for med...

8 months ago - GlobeNewsWire

iSpecimen Inc. (ISPC) Q4 2023 Earnings Call Transcript

iSpecimen Inc. (ISPC) Q4 2023 Earnings Call Transcript

10 months ago - Seeking Alpha

iSpecimen Reports Full Year 2023 Results

LEXINGTON, Mass., March 14, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc.  (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for med...

10 months ago - GlobeNewsWire

iSpecimen Reschedules Full Year 2023 Earnings Release and Conference Call

The Company will now report results after the market closes on March 13, 2024 and reschedules conference call to Thursday, March 14, 2024 at 8:30am Eastern The Company will now report results after th...

10 months ago - GlobeNewsWire

iSpecimen to Report Full Year 2023 Financial Results on March 13, 2024

LEXINGTON, Mass., March 05, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc.  (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for med...

10 months ago - GlobeNewsWire

iSpecimen and TriMetis Life Sciences Announce Strategic Partnership to Help Transform Tissue-Based Research

Partnership Aims to Optimize Quality Control and Assurance Through Digital AI Histopathology Services Partnership Aims to Optimize Quality Control and Assurance Through Digital AI Histopathology Servi...

11 months ago - GlobeNewsWire

iSpecimen to Participate in Maxim Group Healthcare IT Virtual Conference, January 24 & 25, 2024

LEXINGTON, Mass., Jan. 18, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medic...

1 year ago - GlobeNewsWire

iSpecimen Strengthens Global Oncology Biospecimen Offering

Adds New Suppliers and Expands Existing Relationships to Provide Researchers Increased Access to Highly-Sought-After Biospecimens to Advance Oncology Research Adds New Suppliers and Expands Existing R...

1 year ago - GlobeNewsWire

iSpecimen Inc. (ISPC) Q3 2023 Earnings Call Transcript

iSpecimen Inc. (NASDAQ:ISPC) Q3 2023 Earnings Conference Call November 2, 2023 8:30 AM ET Company Participants Phil Carlson - Investor Relations, KCSA Strategic Communications Tracy Curley - Chief Ex...

1 year ago - Seeking Alpha

iSpecimen Reports Third Quarter 2023 Financial and Operating Results

Sequential Quarterly Revenue Growth of 75% Driven by Enhanced Operational Efficiencies of iSpecimen Marketplace and Rollout of New Business Initiatives Sequential Quarterly Revenue Growth of 75% Drive...

1 year ago - GlobeNewsWire

iSpecimen Expands Proprietary Provider Network to Help Advance Infectious Disease Research

New Providers Facilitate Access to Diverse and Hard-to-Reach Populations and Support Complex Custom Projects New Providers Facilitate Access to Diverse and Hard-to-Reach Populations and Support Comple...

1 year ago - GlobeNewsWire

iSpecimen Preannounces Third Quarter 2023 Revenue Increase of 60-70% Sequentially

Management to Host Third Quarter 2023 Conference Call on Thursday, November 2, 2023 Management to Host Third Quarter 2023 Conference Call on Thursday, November 2, 2023

1 year ago - GlobeNewsWire